Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Shoulder

NCT02844738 is registered in ClinicalTrials.gov with VivaTech International, Inc. as lead sponsor.

NCT NCT02844738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02844738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Shoulder
Lead sponsor
VivaTech International, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
July 31, 2015
Completion date
August 31, 2026
Enrollment
4,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis